UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.500

Sortiert nach

Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer

British journal of surgery, 2019-09, Vol.106 (10), p.1381-1392

2019

Volltextzugriff (PDF)

Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray

British journal of cancer, 2014-09, Vol.111 (7), p.1363-1372

2014

Volltextzugriff (PDF)

SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer

European journal of cancer (1990), 2019-09, Vol.119, p.158-167

2019

Volltextzugriff (PDF)

FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study

Annals of oncology, 2015-07, Vol.26 (7), p.1427-1433

2015

Volltextzugriff (PDF)

Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer

BJS open, 2019-12, Vol.3 (6), p.822-829

2019

Volltextzugriff (PDF)

Relation of overall survival, progression free survival, post progression survival and response rate in four randomized Japanese phase III trials comparing various combinations of S-1 therapy for first-line treatment of advanced gastric cancer

Annals of oncology, 2018-10, Vol.29, p.viii231-viii231

2018

Volltextzugriff (PDF)

Serum heat shock protein 27 levels in patients with systemic sclerosis: a possible biomarker of skin sclerosis

Journal of the European Academy of Dermatology and Venereology, 2021-02, Vol.35 (2), p.e157-e159

2021

Volltextzugriff (PDF)

P-276Safety and Efficacy of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Patients with Chemotherapy-Naive Metastatic Colorectal Cancer (SAPPHIRE)

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii80-ii80

2016

Volltextzugriff (PDF)

Phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results

Annals of oncology, 2018-11, Vol.29, p.ix34-ix35

2018

Volltextzugriff (PDF)

An exploratory study of intraperitoneal paclitaxel combined with mFOLFOX6 for peritoneal disseminated gastric cancer patients with inadequate oral intake

Annals of oncology, 2018-10, Vol.29, p.viii230-viii230

2018

Volltextzugriff (PDF)

A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy for colorectal cancer: The AIRS study

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii161

2018

Volltextzugriff (PDF)

Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Bone marrow transplantation (Basingstoke), 2013-11, Vol.48 (11), p.1389-1394

2013

Volltextzugriff (PDF)

Long-term outcome in Japanese patients with lupus nephritis

Lupus, 2014-10, Vol.23 (11), p.1124-1132

2014

Volltextzugriff (PDF)

Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress

Annals of oncology, 2018-06, Vol.29, p.v83-v83

2018

Volltextzugriff (PDF)

A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study

Annals of oncology, 2018-06, Vol.29, p.v71-v71

2018

Volltextzugriff (PDF)

Phase II study of trifluridine/tipiracil plus bevacizumab by RAS mutation status in patients with metastatic colorectal cancer refractory to standard therapies: JFMC51-1702-C7

ESMO open, 2021-04, Vol.6 (2), p.100093-100093, Article 100093

2021

Volltextzugriff (PDF)

Commissioning Test Results of Variable-Temperature Helium Refrigerator/Liquefier for NIFS Superconducting Magnet Test Facility

IEEE transactions on applied superconductivity, 2016-04, Vol.26 (3), p.1-4

2016

Volltextzugriff (PDF)

SAPPHIRE: A randomized phase II study of oxaliplatin discontinuation after 6 cycles of mFOLFOX6 + panitumumab therapy in patients with colorectal cancer: Final analysis of efficacy and safety results

Annals of oncology, 2018-06, Vol.29, p.v95-v95

2018

Volltextzugriff (PDF)

Prospective Phase II Study of FOLFIRI for mCRC in Japan, Including the Analysis of UGT1A128/6 Polymorphisms

Japanese journal of clinical oncology, 2011-04, Vol.41 (4), p.477-482

2011

Volltextzugriff (PDF)

Effects of sex and age on serum 1,5-anhydroglucitol in nondiabetic subjects

Experimental and clinical endocrinology & diabetes, 2012-05, Vol.120 (5), p.288

2012

Volltextzugriff (PDF)

AB0293 High Serum Levels of Anti-Cyclic Citrullinated Peptide Antibody and Matrix Metalloproteinase-3 at the Time of Diagnosis of Rheumatoid Arthritis Are Possible Predictors of Future Initiation of Biological Agents

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.991-991

2015

Volltextzugriff (PDF)

P-157A phase II study of XELOX and Cetuximab (Erbitux) as first-line therapy in patients with KRAS wild-type metastatic colorectal cancer (FLEET2)

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii46-ii46

2016

Volltextzugriff (PDF)

Additional intraoral radiographs may change the judgment regarding the final position of orthodontic mini-implants

Dental press journal of orthodontics, 2018-03, Vol.23 (2), p.54-61

2018

Volltextzugriff (PDF)

An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer

British journal of cancer, 2007-04, Vol.96 (8), p.1170-1177

2007

Volltextzugriff (PDF)

Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission

Blood cancer journal (New York), 2013-11, Vol.3 (11), p.e164-e164

2013

Volltextzugriff (PDF)

1 – 25 von 1.500

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.079)
Mit Volltextzugriff
(1.264)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(795)
Life Sciences & Biomedicine
(486)
Humans
(409)
Male
(287)
Female
(262)
Physical Sciences
(214)
Middle Aged
(197)
Biological And Medical Sciences
(195)
Technology
(182)
Animals
(165)
Adult
(164)
Aged
(141)
Exact Sciences And Technology
(115)
Medical Sciences
(114)
Fundamental And Applied Biological Sciences. Psychology
(94)
Chemistry
(90)
Physics
(87)
Computer Science
(73)
Biochemistry & Molecular Biology
(72)
Applied Sciences
(67)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer

Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray

SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer

FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study

Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer

Relation of overall survival, progression free survival, post progression survival and response rate in four randomized Japanese phase III trials comparing various combinations of S-1 therapy for first-line treatment of advanced gastric cancer

Serum heat shock protein 27 levels in patients with systemic sclerosis: a possible biomarker of skin sclerosis

P-276Safety and Efficacy of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Patients with Chemotherapy-Naive Metastatic Colorectal Cancer (SAPPHIRE)

Phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results

An exploratory study of intraperitoneal paclitaxel combined with mFOLFOX6 for peritoneal disseminated gastric cancer patients with inadequate oral intake

A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy for colorectal cancer: The AIRS study

Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Long-term outcome in Japanese patients with lupus nephritis

Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress

A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study

Phase II study of trifluridine/tipiracil plus bevacizumab by RAS mutation status in patients with metastatic colorectal cancer refractory to standard therapies: JFMC51-1702-C7

Commissioning Test Results of Variable-Temperature Helium Refrigerator/Liquefier for NIFS Superconducting Magnet Test Facility

SAPPHIRE: A randomized phase II study of oxaliplatin discontinuation after 6 cycles of mFOLFOX6 + panitumumab therapy in patients with colorectal cancer: Final analysis of efficacy and safety results

Prospective Phase II Study of FOLFIRI for mCRC in Japan, Including the Analysis of UGT1A128/6 Polymorphisms

Effects of sex and age on serum 1,5-anhydroglucitol in nondiabetic subjects

AB0293 High Serum Levels of Anti-Cyclic Citrullinated Peptide Antibody and Matrix Metalloproteinase-3 at the Time of Diagnosis of Rheumatoid Arthritis Are Possible Predictors of Future Initiation of Biological Agents

P-157A phase II study of XELOX and Cetuximab (Erbitux) as first-line therapy in patients with KRAS wild-type metastatic colorectal cancer (FLEET2)

Additional intraoral radiographs may change the judgment regarding the final position of orthodontic mini-implants

An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer

Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission

Suchergebnisse filtern